Lawrence B. Werlin, a leader in fertility and reproductive medicine, recently unveiled two new fertility studies at the annual American Society of Reproductive Medicine conference (ASRM). Werlin’s breakthrough fertility studies focused on the use of Preimplantation Genetic Diagnosis (PGD) for women of advanced maternal age (over 38) and those in high-risk categories.